• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SAHA 通过降低组蛋白去乙酰化酶和细胞周期蛋白 D1 和存活素的表达来抑制结肠肿瘤的生长。

SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.

机构信息

Department of Pathology, Tungs' Taichung MetroHarbor Hospital, Wuqi Township, Taichung County, Taiwan, Republic of China.

出版信息

Pathol Oncol Res. 2012 Jul;18(3):713-20. doi: 10.1007/s12253-012-9499-7. Epub 2012 Jan 20.

DOI:10.1007/s12253-012-9499-7
PMID:22270866
Abstract

We studied the effects of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor, on colon cancer. The expression of HDACs in colorectal cancer specimens and the effects of SAHA on colon cancer cells and tumors of nude mice were assessed. Treatment with SAHA (3 μm) for 72 h induced downregulation of different subtypes of HDAC proteins and also induced acetylation of histone 3 and histone 4. SAHA significantly inhibited the expression of the oncogenic protein c-myc and also increased the expression of the p53 and Rb proteins. The immunohistochemical staining of HDACs, including HDAC1, HDAC2, HDAC3, and HDAC4, was significantly increased in colorectal adenocarcinoma specimens compared to healthy control tissues. In addition, murine studies showed that 100 mg/kg SAHA administered by intraperitoneal injection significantly induced tumor necrosis and inhibited the growth of colon tumors. Immunohistochemistry of the tumor tissues from nude mice revealed that SAHA inhibited the expression of different subtypes of histone deacetylase, the anti-apoptotic proteins cyclin D1, survivin, and also inhibited cell proliferative as determined by Ki67 expression. SAHA inhibited the growth of colon tumors by decreasing histone deacetylases and the expression of cyclin D1 and survivin in nude mice.

摘要

我们研究了琥珀酰亚胺基草酰苯胺(SAHA),一种组蛋白去乙酰化酶(HDAC)抑制剂,对结肠癌的影响。评估了 HDAC 在结直肠肿瘤标本中的表达以及 SAHA 对结肠癌细胞和裸鼠肿瘤的影响。用 SAHA(3μm)处理 72 小时诱导了不同亚型的 HDAC 蛋白的下调,也诱导了组蛋白 3 和组蛋白 4 的乙酰化。SAHA 显著抑制了致癌蛋白 c-myc 的表达,同时增加了 p53 和 Rb 蛋白的表达。与健康对照组织相比,结直肠腺癌标本中 HDACs(包括 HDAC1、HDAC2、HDAC3 和 HDAC4)的免疫组织化学染色明显增加。此外,鼠类研究表明,腹腔注射 100mg/kg 的 SAHA 可显著诱导肿瘤坏死并抑制结肠肿瘤的生长。裸鼠肿瘤组织的免疫组织化学分析表明,SAHA 抑制了不同亚型组蛋白去乙酰化酶、抗凋亡蛋白 cyclin D1、survivin 的表达,并通过 Ki67 表达抑制细胞增殖。SAHA 通过降低组蛋白去乙酰化酶和 cyclin D1、survivin 的表达来抑制裸鼠结肠肿瘤的生长。

相似文献

1
SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.SAHA 通过降低组蛋白去乙酰化酶和细胞周期蛋白 D1 和存活素的表达来抑制结肠肿瘤的生长。
Pathol Oncol Res. 2012 Jul;18(3):713-20. doi: 10.1007/s12253-012-9499-7. Epub 2012 Jan 20.
2
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.辛二酰苯胺异羟肟酸(伏立诺他/泽珂)使原位植入BALB/c裸鼠体内的对肿瘤坏死因子相关凋亡诱导配体(TRAIL)耐药的乳腺癌细胞敏感化。
Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.
3
Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.迷迭香酸,迷迭香茶的一种成分,通过调节前列腺癌细胞系中 HDAC2 的表达诱导细胞周期停滞和细胞凋亡。
Nutrients. 2018 Nov 16;10(11):1784. doi: 10.3390/nu10111784.
4
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.组蛋白去乙酰化酶抑制剂的结构要求:C4修饰的SAHA类似物具有HDAC6/HDAC8双重选择性。
Eur J Med Chem. 2018 Jan 1;143:1790-1806. doi: 10.1016/j.ejmech.2017.10.076. Epub 2017 Oct 31.
5
Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.组蛋白去乙酰化酶(HDAC)抑制剂,丁酸钠(SAHA),通过 Akt/FOXO3a 信号通路诱导前列腺癌细胞系凋亡。
Med Sci Monit. 2017 Dec 6;23:5793-5802. doi: 10.12659/msm.904597.
6
Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.琥珀酰亚胺基戊二酰胺酸诱导 320 HSR 结肠癌细胞凋亡和 G1 期阻滞。
J Biomed Sci. 2010 Sep 17;17(1):76. doi: 10.1186/1423-0127-17-76.
7
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.组蛋白去乙酰化酶抑制剂的结构要求:基于异羟肟酸修饰的SAHA类似物
Arch Pharm (Weinheim). 2016 May;349(5):373-82. doi: 10.1002/ardp.201500472. Epub 2016 Apr 9.
8
Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.琥珀酰亚胺基戊二酰胺抑制组蛋白去乙酰化酶:治疗人子宫肌瘤的一种方法。
Fertil Steril. 2022 Feb;117(2):433-443. doi: 10.1016/j.fertnstert.2021.10.012. Epub 2021 Nov 19.
9
Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.辛二酰苯胺异羟肟酸通过上调肺癌细胞中肿瘤坏死因子受体1增强肿瘤坏死因子-α的抗癌作用。
Oncotarget. 2017 Mar 14;8(11):17726-17737. doi: 10.18632/oncotarget.14628.
10
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.组蛋白去乙酰化酶抑制剂与DNA损伤剂之间的协同作用由结直肠癌中的组蛋白去乙酰化酶2介导。
Oncotarget. 2016 Jul 12;7(28):44505-44521. doi: 10.18632/oncotarget.9887.

引用本文的文献

1
Potentials of N-Acyl Hydrazones Against Colorectal Cancer: A Mini Review.N-酰基腙类化合物抗结直肠癌的潜力:一篇综述
Anticancer Agents Med Chem. 2025;25(17):1273-1286. doi: 10.2174/0118715206356253241223040825.
2
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.辛二酰苯胺异羟肟酸(SAHA),一种组蛋白去乙酰化酶(HDAC)抑制剂,通过靶向胶质瘤干细胞中的c-Myc/CCL1途径抑制调节性T细胞(Treg细胞)的作用,并改善程序性死亡受体配体1(PD-L1)阻断疗法。
J Neurooncol. 2024 Jul;168(3):457-471. doi: 10.1007/s11060-024-04689-0. Epub 2024 Apr 23.
3

本文引用的文献

1
Redox modulation of p53: mechanisms and functional significance.氧化还原调节 p53:机制和功能意义。
Mol Carcinog. 2011 Apr;50(4):222-34. doi: 10.1002/mc.20709.
2
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.Meta 分析胰腺切除术后肿瘤组织中免疫组化预后标志物的作用
Br J Cancer. 2011 Apr 26;104(9):1440-51. doi: 10.1038/bjc.2011.110. Epub 2011 Mar 29.
3
Nuclear protein isoforms: implications for cancer diagnosis and therapy.核蛋白亚型:癌症诊断与治疗的启示。
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.
组蛋白去乙酰化酶6及组蛋白去乙酰化酶6抑制在结直肠癌中的作用
Pharmaceutics. 2023 Dec 29;16(1):54. doi: 10.3390/pharmaceutics16010054.
4
Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.将 Neprilysin 抑制剂“沙库巴曲”通过调节表观遗传和凋亡调节剂重新用于抗癌药物。
Sci Rep. 2023 Jun 19;13(1):9952. doi: 10.1038/s41598-023-36872-0.
5
Microstructured soft devices for the growth and analysis of populations of homogenous multicellular tumor spheroids.用于同质多细胞肿瘤球体群体生长和分析的微结构软设备。
Cell Mol Life Sci. 2023 Mar 16;80(4):93. doi: 10.1007/s00018-023-04748-1.
6
High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors.非功能性垂体瘤中组蛋白去乙酰化酶2/3的高表达
Front Oncol. 2022 May 13;12:875122. doi: 10.3389/fonc.2022.875122. eCollection 2022.
7
Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer.衰老标记蛋白30通过降低非小细胞肺癌中HDAC4的表达来抑制肿瘤生长。
Transl Lung Cancer Res. 2021 Dec;10(12):4558-4573. doi: 10.21037/tlcr-21-982.
8
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.靶向组蛋白去乙酰化酶:癌症治疗与化学预防的机遇
Pharmaceutics. 2022 Jan 16;14(1):209. doi: 10.3390/pharmaceutics14010209.
9
Histone Modifications and their Role in Colorectal Cancer (Review).组蛋白修饰及其在结直肠癌中的作用(综述)
Pathol Oncol Res. 2020 Oct;26(4):2023-2033. doi: 10.1007/s12253-019-00663-8. Epub 2019 May 4.
10
ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.ING5 介导的丁酰苯类化合物对神经母细胞瘤的抑制作用。
Cancer Med. 2018 Sep;7(9):4554-4569. doi: 10.1002/cam4.1634. Epub 2018 Aug 9.
J Cell Biochem. 2011 Mar;112(3):756-60. doi: 10.1002/jcb.23002.
4
Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.琥珀酰亚胺基戊二酰胺酸诱导 320 HSR 结肠癌细胞凋亡和 G1 期阻滞。
J Biomed Sci. 2010 Sep 17;17(1):76. doi: 10.1186/1423-0127-17-76.
5
Functional outcome following restorative rectal cancer surgery.直肠癌修复性手术后的功能结局。
Acta Chir Iugosl. 2009;56(2):9-16. doi: 10.2298/aci0902009z.
6
Targeted therapy for advanced colorectal cancer--more is not always better.晚期结直肠癌的靶向治疗——并非越多越好。
N Engl J Med. 2009 Feb 5;360(6):623-5. doi: 10.1056/NEJMe0809343.
7
An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.一种组蛋白去乙酰化酶(HDAC)抑制剂曲古抑菌素A以转录依赖的方式诱导细胞在G2/M期转换时出现延迟、纺锤体检查点滑脱及细胞死亡。
Biochem Biophys Res Commun. 2009 Jan 16;378(3):326-31. doi: 10.1016/j.bbrc.2008.11.057. Epub 2008 Nov 25.
8
Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment.雌激素和抗雌激素对多细胞球体中乳腺癌细胞增殖的依赖性调节:细胞微环境的影响
Int J Oncol. 2008 May;32(5):1033-9. doi: 10.3892/ijo.32.5.1033.
9
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.I 类组蛋白去乙酰化酶的表达对人类结直肠癌具有独立的预后影响:I 类组蛋白去乙酰化酶在体外和体内的特定作用。
Clin Cancer Res. 2008 Mar 15;14(6):1669-77. doi: 10.1158/1078-0432.CCR-07-0990.
10
Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.表皮生长因子受体的高表达与大肠腺癌中的细胞外基质金属蛋白酶诱导剂相关:免疫染色评分与临床病理参数的组织芯片分析
Dis Markers. 2006;22(5-6):309-16. doi: 10.1155/2006/890810.